[Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH]

Onkologie. 2010:33 Suppl 3:2-20. doi: 10.1159/000290758. Epub 2010 Apr 23.
[Article in German]
No abstract available

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies / blood
  • Benzoates / adverse effects
  • Benzoates / therapeutic use
  • Blood Coagulation Tests
  • Blood Platelets / immunology
  • Blood Transfusion
  • Child
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Evidence-Based Medicine*
  • Germany
  • Hemorrhage / classification
  • Hemorrhage / etiology
  • Hospitalization
  • Humans
  • Hydrazines / adverse effects
  • Hydrazines / therapeutic use
  • Immunization, Passive*
  • Immunosuppressive Agents / therapeutic use*
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / blood
  • Purpura, Thrombocytopenic, Idiopathic / diagnosis*
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / etiology
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use
  • Receptors, Fc / therapeutic use
  • Receptors, Thrombopoietin / agonists*
  • Recombinant Fusion Proteins / adverse effects
  • Recombinant Fusion Proteins / therapeutic use
  • Recurrence
  • Rituximab
  • Splenectomy
  • Thrombopoietin / adverse effects
  • Thrombopoietin / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Benzoates
  • Hydrazines
  • Immunosuppressive Agents
  • Pyrazoles
  • Receptors, Fc
  • Receptors, Thrombopoietin
  • Recombinant Fusion Proteins
  • MPL protein, human
  • Rituximab
  • Thrombopoietin
  • romiplostim
  • eltrombopag